Jubilant Pharmova slipped 3.70% to Rs 726.45 after the United States Food and Drug Administration (USFDA) has concluded audit of the Jubilant HollisterStier General Partnership (JHSGP)’s contract manufacturing facility at Montreal, Canada.
| Subscribe To Our Free Newsletter |
